Personalized Treatment: Finding the Right GLP-1 Medication Not all GLP-1 medications work the same way for everyone, which is why its important to find the right one based on your individual health needs and goals
Hair-, Skin-, and Connective-Tissue Research Glow Blend is frequently investigated in research involving: Hair- and scalp-related pathways Skin-quality and dermal-support mechanisms Connective-tissue and tissue-maintenance pathways Collagen-related and regenerative signaling Physiological-maintenance research Because Glow Blend combines peptides researched for complementary regenerative pathways, it is commonly investigated as a multi-pathway skin-integrity and tissue-maintenance research formulation
For inflammatory bowel disease, mesalamine, corticosteroids, immunomodulators (azathioprine, methotrexate), and biologics (infliximab, adalimumab, vedolizumab, ustekinumab) all have Level 1 evidence from Phase III trials with thousands of patients
ConsumerLab reviews the evidence for OsteoMD by 1MD, a bone health supplement promoted to slow bone loss and reduce the risk of osteoporosis
Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients